A cell-impermeable kinase inhibitor uncovers outside-in signaling pathways that promote HIV-1 infection. [PDF]
Vinzant K +9 more
europepmc +1 more source
Maraviroc for Stroke Recovery (MASTER): protocol for a phase 2 double-blind placebo-controlled randomised clinical trial. [PDF]
Broc N +3 more
europepmc +1 more source
Tumor Necrosis Factor Receptor 2 Inhibits HIV-1 Infection by Blocking the Binding of gp120 to CD4. [PDF]
Gao Y +8 more
europepmc +1 more source
Coreceptor usage of plasma and cerebrospinal fluid-derived HIV-1 subtype C variants. [PDF]
Sirkisson S +5 more
europepmc +1 more source
Fingolimod increases cellular resistance to HIV-1 infection and limits viral reservoir size in peripheral CD4+ T-cells. [PDF]
Moraga E +12 more
europepmc +1 more source
Astrocytic CCL5 orchestrates CCR5-positive neuronal necroptosis in subarachnoid hemorrhage. [PDF]
Chen P +11 more
europepmc +1 more source
CCR5Δ32 polymorphism is associated with increased central memory CD4+ T cells in virologically suppressed people living with HIV on antiretroviral therapy. [PDF]
Lopes-Araujo HF +10 more
europepmc +1 more source
Pharmacological and Genetic Targeting of Inflammatory Chemokine Receptors CCR1, CCR2, and CCR5 in Atherosclerosis: A Systematic Review and Meta-Analysis of Preclinical Studies. [PDF]
Shoaran M +9 more
europepmc +1 more source

